| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3626038 | F | Antiviral activity against human cytomegalovirus AD169 infected in HEL cells assessed as reduction in viral plaque formation | Human betaherpesvirus 5 | 21 | ALA3621200 | organism-based format | Scientific Literature | |
| 2. | ALA3626039 | F | Antiviral activity against human cytomegalovirus Davis infected in HEL cells assessed as reduction in viral plaque formation | Human betaherpesvirus 5 | 21 | ALA3621200 | organism-based format | Scientific Literature | |
| 3. | ALA3626040 | A | Cytotoxicity against human cytomegalovirus infected HEL cells assessed as alteration of cell morphology incubated for 3 days by microscopy | Homo sapiens | 21 | ALA3621200 | cell-based format | Scientific Literature | |
| 4. | ALA3626044 | F | Antiviral activity against thymidine kinase-deficient Varicella zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation | Human alphaherpesvirus 3 | 21 | ALA3621200 | organism-based format | Scientific Literature | |
| 5. | ALA3626147 | F | Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation | Human alphaherpesvirus 3 | 21 | ALA3621200 | organism-based format | Scientific Literature | |
| 6. | ALA3626148 | A | Cytotoxicity against Varicella zoster virus infected HEL cells assessed as alteration of cell morphology incubated for 3 days by microscopy | Homo sapiens | 21 | ALA3621200 | cell-based format | Scientific Literature | |
| 7. | ALA3626150 | F | Antiviral activity against HSV1 KOS | Human alphaherpesvirus 1 | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 8. | ALA3626151 | F | Antiviral activity against HSV2 Lyons | Human alphaherpesvirus 2 | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 9. | ALA3626152 | F | Antiviral activity against HSV2 G Lyons | Human herpesvirus 2 strain G | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 10. | ALA3626153 | F | Antiviral activity against Vaccinia virus Lederle | Vaccinia virus | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 11. | ALA3626154 | F | Antiviral activity against Vesicular stomatitis virus | Vesicular stomatitis virus | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 12. | ALA3626155 | F | Antiviral activity against Human coxsackievirus B4 | Coxsackievirus B4 | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 13. | ALA3626156 | F | Antiviral activity against Influenza A virus H3N2 | Influenza A virus H3N2 | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 14. | ALA3626157 | F | Antiviral activity against Influenza A virus H1N1 | Influenza A virus | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 15. | ALA3626158 | F | Antiviral activity against Influenza B virus | Influenza B virus | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 16. | ALA3626159 | F | Antiviral activity against Parainfluenza 3 virus | Human respirovirus 3 | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 17. | ALA3626160 | F | Antiviral activity against Reovirus 1 | Mammalian orthoreovirus 1 | 19 | ALA3621200 | assay format | Scientific Literature | |
| 18. | ALA3626161 | F | Antiviral activity against Sindbis virus | Sindbis virus | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 19. | ALA3626162 | F | Antiviral activity against Punta Toro virus | Punta Toro virus | 19 | ALA3621200 | organism-based format | Scientific Literature | |
| 20. | ALA3626163 | F | Antiviral activity against Feline coronavirus | Feline coronavirus | 19 | ALA3621200 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!